pharmaceuticals
pharmaceuticals Articles
A new Jefferies research report makes the case that while market parameters are indeed expensive, there still are cheap stocks to buy that have a large enough market cap to provide some safety.
Published:
Last Updated:
Not that many biotech and pharma companies were on the move Thursday, just one day before the inauguration. However, a few of the smaller caps made splash.
Published:
Last Updated:
Trump said last week that companies in the health care sector are “getting away with murder,” and that something had to change. The sector has pulled back slightly since then, but there are still...
Published:
Last Updated:
This acquisition not only will enhance Eli Lilly's existing portfolio in pain management for migraine, but it also adds a potential near-term launch to its late-stage pipeline.
Published:
Last Updated:
A few biotech and pharma companies were on the move Tuesday. A few of the smaller caps made tremendous gains on the day, as the fourth-quarter earnings season is kicking off.
Published:
Last Updated:
The health care sector was in trouble over the past year, under fire from congressional hearings and politicians on the campaign trail. At first 2017 seemed like it could be different for this...
Published:
Last Updated:
The the attacks against drug pricing and competition do not seem to be going away, but somehow, Merck has managed to find itself as a top pick for pharmaceutical and biohealth analysts.
Published:
Last Updated:
The short interest data have been released for the December 30 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through...
Published:
Last Updated:
Biotech and pharma companies were on the move Wednesday. A few of the smaller caps made tremendous gains on the day, while a couple of the major firms saw massive volume and a slight move. Although...
Published:
Last Updated:
Valeant Pharmaceuticals made waves early on Tuesday after the company offered announcements of a late-stage psoriasis trial and the sale of a couple business segments.
Published:
Last Updated:
As the second week of the New Year is now underway, a few biotech companies made sizable runs to kick off the week.
Published:
Last Updated:
Although the tailwind of the Trump rally has been incredibly strong, there are still companies holding back this rally. In fact, the Dow was just barely short of hitting the 20,000 mark for the first...
Published:
Last Updated:
2017 could be different for the health care sector. It is very possible that this new administration could lead to more positive trials, FDA approvals, and mergers and acquisitions.
Published:
Last Updated:
Some biopharma companies can see a massive upside just from winning a single mid-stage trial or even achieving as much as a Fast Track designation from the FDA.
Published:
Last Updated:
A new Jefferies research report makes the case that five top biotech companies may be right in the cross-hairs of the biotech giants or perhaps large pharmaceutical companies.
Published:
Last Updated: